Leukemias arising from MLL translocations have a characteristic signature of increased HOXA9 and MEIS1 expression. Maintenance of the leukemic state requires continued expression of both genes. Knockdown of either HOXA9 or MEIS1 expression results in a loss of leukemogenic potential.